How grim is pancreatic cancer?

  • Elroy Patrick Weledji | elroypat@yahoo.co.uk Department of Surgery and Obstetrics and Gynaecology, University of Buea, Cameroon.
  • George Enoworock Department of Pathology, University of Buea, Cameroon.
  • Martin Mokake Department of Surgery and Obstetrics and Gynaecology, University of Buea, Cameroon.
  • Motaze Sinju Department of Surgery and Obstetrics and Gynaecology, University of Buea, Cameroon.

Abstract

Pancreatic ductal carcinoma continues to be the most lethal malignancy with rising incidence. It is the fourth most common cause of cancer death in the western world due to its low treatment success rate. In addition, because of its rapid growth and silent course, diagnosis is often only established in the advanced stages. As one of the most aggressive malignancies, the treatment of this disease is a great challenge to clinicians. This paper reviewed the natural history of pancreatic cancer, the current clinical practice and the future in pancreatic cancer management.

Downloads

Download data is not yet available.

Author Biography

Elroy Patrick Weledji, Department of Surgery and Obstetrics and Gynaecology, University of Buea

Senior lecturer in Anatomy and clinical Surgery

Department of surgery, Faculty of Health Sciences,

University of Buea

Published
2016-07-06
Section
Reviews
Keywords:
Cancer, pancreas, prognosis, management.
Statistics
Abstract views: 2084

PDF: 706
HTML: 3010
Share it

PlumX Metrics

PlumX Metrics provide insights into the ways people interact with individual pieces of research output (articles, conference proceedings, book chapters, and many more) in the online environment. Examples include, when research is mentioned in the news or is tweeted about. Collectively known as PlumX Metrics, these metrics are divided into five categories to help make sense of the huge amounts of data involved and to enable analysis by comparing like with like.

How to Cite
Weledji, E., Enoworock, G., Mokake, M., & Sinju, M. (2016). How grim is pancreatic cancer?. Oncology Reviews, 10(1). https://doi.org/10.4081/oncol.2016.294